COPD

Lung function and health status decreases across all levels of severity.

Patients with a burn injury were twice as likely to have been prescribed oxygen in the previous 90 days.

High hospital readmission rates plague the health care system.

Study finds many patients use propellant-based metered-dose inhalers incorrectly.

This Continuing Education activity is supported by educational grants from AstraZeneca LP and Boehringer Ingelheim Pharmaceuticals, Inc.

Respiratory diseases afflict a large portion of the global population and result in significant disease burden.

Here are new drugs for 2015 pharmacists can expect to handle.

Reslizumab targets a key cytokine involved in elevating levels of blood eosinophils.

Once-daily drug can be used to treat chronic bronchitis and emphysema.

The FDA today approved a new treatment for chronic obstructive pulmonary disease: tiotropium bromide and olodaterol inhalation spray.

Pharmacists need to remain cognizant of COPD and asthma patient preferences to maintain adherence.

Clinical guidelines and government agencies are increasingly encouraging clinicians to consider patients' treatment preferences when chronic disease is present.

Link found between new onset obstructive sleep apnea and habitual sleepiness.

Carmela Avena-Woods, BSPharm, PharmD, CGP, assistant clinical professor of clinical pharmacy practice in the College of Pharmacy and Health Sciences at St. John's University, talks about what the teach-back method is and the pharmacist's role in patient counseling.

The FDA today expanded the indication of fluticasone furoate/vilanterol (Breo Ellipta) for the treatment of asthma.

Difficulty with several aspects of nebulizer use creates treatment hurdles for patients.

COPD patients must clear major hurdles before and after initiating nebulizer use.

Carmela Avena-Woods, BSPharm, PharmD, CGP, assistant clinical professor of clinical pharmacy practice in the College of Pharmacy and Health Sciences at St. John's University, details some factors that contribute to nonadherence among patients with COPD.

Carmela Avena-Woods, BSPharm, PharmD, CGP, assistant clinical professor of clinical pharmacy practice in the College of Pharmacy and Health Sciences at St. John's University, talks about the importance of individualizing treatment for COPD.

Carmela Avena-Woods, BSPharm, PharmD, CGP, assistant clinical professor of clinical pharmacy practice in the College of Pharmacy and Health Sciences at St. John's University, talks about the burden COPD places on society.

Chronic obstructive pulmonary disease Is preventable and treatable, especially if diagnosed early.

Chronic obstructive pulmonary disease Is preventable and treatable, especially if diagnosed early.

Well-trained pharmacists can successfully screen patients for COPD in the community setting.

Well-trained pharmacists can successfully screen patients for COPD in the community setting.

Hospital readmissions are a major driver of spending in the Medicare program.

Several new treatments for COPD are in development.

Effective management of COPD can improve quality of life for patients and help reduce rehospitalizations.

From optimizing inhaler technique in patients with chronic obstructive pulmonary disease, to catching red flags when dispensing controlled substances to patients with chronic pain, pharmacists can improve patient outcomes in an evolving treatment landscape.

Leonard Nimoy's recent death from end-stage chronic obstructive pulmonary disease (COPD) brought the condition into the spotlight, and may bring patients with questions to the pharmacy counter.